Raday Gilead
SEC insider (Form 3/4/5 filer). CIK 0002113137. Chief Operating Officer at RedHill Biopharma Ltd. (RDHL). 6 reported Form 4/5 transactions since Sep 2024; latest on Oct 1, 2026. Located in TEL AVIV.
Companies Raday Gilead has filed insider reports for
- RedHill Biopharma Ltd. (RDHL): Officer, Chief Operating Officer
Raday Gilead
CIK: 0002113137
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RedHill Biopharma Ltd.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Oct 1, 2026RDHL
RedHill Biopharma Ltd.
SaleDirect14.3M shares at avg. $0.00$1K - Oct 1, 2026RDHL
RedHill Biopharma Ltd.
ExerciseDirectAmerican Depository Shares
27.6M shares- - Jul 10, 2026RDHL
RedHill Biopharma Ltd.
SaleDirect14.1M shares at avg. $0.00$1K - Jul 10, 2026RDHL
RedHill Biopharma Ltd.
ExerciseDirectAmerican Depositary Shares
28.2M shares- - Apr 6, 2026RDHL
RedHill Biopharma Ltd.
SaleDirect15.7M shares at avg. $0.00$2K - Apr 6, 2026RDHL
RedHill Biopharma Ltd.
ExerciseDirectAmerican Depositary Shares
30.8M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 | RDHL RedHill Biopharma Ltd. | Sale | 14,310,000 | $0.00 | $1,431 | Direct |
| Oct 1, 2026 | RDHL RedHill Biopharma Ltd. | Exercise American Depository Shares | 27,560,000 | - | - | Direct |
| Jul 10, 2026 | RDHL RedHill Biopharma Ltd. | Sale | 14,130,000 | $0.00 | $1,413 | Direct |
| Jul 10, 2026 | RDHL RedHill Biopharma Ltd. | Exercise American Depositary Shares | 28,150,000 | - | - | Direct |
| Apr 6, 2026 | RDHL RedHill Biopharma Ltd. | Sale | 15,740,000 | $0.00 | $1,574 | Direct |
| Apr 6, 2026 | RDHL RedHill Biopharma Ltd. | Exercise American Depositary Shares | 30,780,000 | - | - | Direct |
1-6 of 6 transactions